
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Kodiak Sciences
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Kodiak is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC PlatformTM uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiaks discovery engine. Kodiaks lead product candidate, tarcocimab tedromer, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including wet age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of dev...
C-Level 0 | VP - Level1 |
Director- | Manager3 |
Others70 |
Structure | Email Format |
---|---|
<f><last>@ |
|
Pain Points | Locations | Technologies |
---|---|---|
Animation | Palo Alto, CA | imaging, cad, ar, vr |
Application Development | Palo Alto, CA | communication, testing, imaging, cad, troubleshooting, ar, vr |
Compliance | Palo Alto, CA | compliance, communication, ada |
Digital Transformation | Palo Alto, CA | communication, compliance, imaging, testing, cad, troubleshooting, ar, ada, vr |
Embedded Design | Palo Alto, CA | communication, compliance, imaging, testing, cad, troubleshooting, ar, ada, vr |
Amazon connect
Gcp
Canvas
Creo
Director
Ar
Archival
Cad
Cgmp
Communication
Kodiak Sciences Inc. is a fast-growing biotechnology company with a focus on ophthalmology. The c...
View MoreKodiak Sciences Inc. is a fast-growing biotechnology company with a focus on ophthalmology. The c...
View MoreKodiak Sciences Inc. is a fast-growing, clinical-stage biopharmaceutical company focused on trans...
View MoreKodiak Sciences is currently offering a unique opportunity to a highly motivated Senior Research ...
View MoreKodiak Sciences Inc. is a fast-growing biotechnology company with a focus on ophthalmology. The c...
View MoreKodiak Sciences Inc. is a fast-growing biotechnology company with a focus on ophthalmology. The c...
View MoreKodiak Sciences Inc. is a fast-growing biotechnology company with a focus on ophthalmology. The c...
View MoreKodiak Sciences Inc. is a fast-growing biotechnology company with a focus on ophthalmology. The c...
View MoreKodiak is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. We are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC PlatformTM uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiaks discovery engine. Kodiaks lead product candidate, tarcocimab tedromer, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including wet age-related macular degeneration, the leading cause...
Kodiak sciences operates in the Biotechnology research industry.
Kodiak sciences's revenue is 11m - 100m
Kodiak sciences has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.